Bausch Health Companies Inc
BHC
Company Profile
Business description
Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum revenue from the Bausch + Lomb segment.
Contact
2150 Saint Elzear Boulvard West
LavalQCH7L 4A8
CANT: +1 514 744-6792
E: arthur.shannon@bauschhealth.com
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2025
Employees
20,700
Stocks News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 7,588.70 | 64.40 | 0.86% |
CAC 40 | 6,927.12 | 347.83 | -4.78% |
DAX 40 | 19,789.62 | 852.10 | -4.13% |
Dow JONES (US) | 37,965.60 | 2,580.33 | -6.36% |
FTSE 100 | 7,702.08 | 352.90 | -4.38% |
HKSE | 19,828.30 | 3,021.51 | -13.22% |
NASDAQ | 15,603.26 | 947.34 | -5.72% |
Nikkei 225 | 32,943.58 | 1,807.00 | 5.80% |
NZX 50 Index | 11,887.54 | 111.66 | 0.95% |
S&P 500 | 5,062.25 | 11.83 | -0.23% |
S&P/ASX 200 | 7,401.30 | 58.00 | 0.79% |
SSE Composite Index | 3,096.58 | 245.43 | -7.34% |